Andere Sprachen Rhythm Pharmaceuticals, Inc.

Aktien

A2H5A0

US76243J1051

RYTM

Realtime-Estimate Cboe BZX Andere Börsenplätze 18:44:26 19.04.2024			% 5 Tage	% 1. Jan.
37.84 ^USD	-0.70%		-6.12%	-17.64%

18.04.	RHYTHM PHARMACEUTICALS, INC. : Wells Fargo Securities bekräftigt seine Kaufempfehlung	ZM
01.04.	Rhythm Pharmaceuticals verkauft wandelbare Vorzugsaktien der Serie A im Wert von $150 Millionen	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Rhythm Pharmaceuticals Announces New Employment Inducement Grants	16.04.
Rhythm Pharmaceuticals to Sell $150 Million in Series A Convertible Preferred Stock	01.04.
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing	01.04.
Rhythm Pharmaceuticals, Inc. announced that it expects to receive $150 million in funding from Perceptive Advisors LLC, C2 Life Sciences, Llc, Perceptive Discovery ID LP	01.04.
Rhythm Pharmaceuticals Doses First Patients in Phase 1 Trial of Potential Obesity Therapy	25.03.
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist	25.03.
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist	25.03.
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist	25.03.
Rhythm Pharmaceuticals Insider Sold Shares Worth $735,600, According to a Recent SEC Filing	22.03.
Rhythm Pharmaceuticals Insider Sold Shares Worth $707,005, According to a Recent SEC Filing	22.03.
Perceptive Advisors Engages in Discussion with Rhythm Pharmaceuticals	20.03.
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing	20.03.
Rhythm Pharmaceuticals Insider Sold Shares Worth $627,520, According to a Recent SEC Filing	20.03.
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing	20.03.
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing	20.03.
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing	20.03.
Rhythm Pharmaceuticals Announces New Employment Inducement Grants	11.03.
Rhythm Pharmaceuticals Announces New Employment Inducement Grants	11.03.
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences	06.03.
Rhythm Pharmaceuticals Says Planning to Add More Japanese Patients to Phase 3 Hypothalamic Obesity Trial	22.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Rhythm Pharmaceuticals, Inc.

Aktien

A2H5A0

US76243J1051

RYTM

Andere Sprachen

Filter